159 related articles for article (PubMed ID: 25037752)
1. The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion.
McAllister IL; Tan MH; Smithies LA; Wong WL
Ophthalmology; 2014 Nov; 121(11):2228-36. PubMed ID: 25037752
[TBL] [Abstract][Full Text] [Related]
2. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.
McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
Ophthalmology; 2010 May; 117(5):954-65. PubMed ID: 20163872
[TBL] [Abstract][Full Text] [Related]
3. Factors promoting success and influencing complications in laser-induced central vein bypass.
McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
Ophthalmology; 2012 Dec; 119(12):2579-86. PubMed ID: 22959103
[TBL] [Abstract][Full Text] [Related]
4. [Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion].
Kabesha TB; Glacet-Bernard A; Rostaqui O; Souied EH
J Fr Ophtalmol; 2015 May; 38(5):414-20. PubMed ID: 25956562
[TBL] [Abstract][Full Text] [Related]
5. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
[TBL] [Abstract][Full Text] [Related]
6. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Arch Ophthalmol; 1997 Apr; 115(4):486-91. PubMed ID: 9109757
[TBL] [Abstract][Full Text] [Related]
7. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
[TBL] [Abstract][Full Text] [Related]
8. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion.
Terui T; Kondo M; Sugita T; Ito Y; Kondo N; Ota I; Miyake K; Terasaki H
Retina; 2011 Jun; 31(6):1068-74. PubMed ID: 21451440
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
10. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases.
Leizaola-Fernández C; Suárez-Tatá L; Quiroz-Mercado H; Colina-Luquez J; Fromow-Guerra J; Jiménez-Sierra JM; Guerrero-Naranjo JL; Morales-Cantón V
BMC Ophthalmol; 2005 May; 5():10. PubMed ID: 15943889
[TBL] [Abstract][Full Text] [Related]
11. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
Chan CK; Ip MS; Vanveldhuisen PC; Oden NL; Scott IU; Tolentino MJ; Blodi BA;
Ophthalmology; 2011 Jul; 118(7):1364-72. PubMed ID: 21440942
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
13. Dilation of the minor arterial circle of the iris preceding rubeosis iridis during retinal vein occlusion.
Paques M; Girmens JF; Rivière E; Sahel J
Am J Ophthalmol; 2004 Dec; 138(6):1083-6. PubMed ID: 15629321
[TBL] [Abstract][Full Text] [Related]
14. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
Hayreh SS; Zimmerman MB
Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
[TBL] [Abstract][Full Text] [Related]
15. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
[TBL] [Abstract][Full Text] [Related]
16. Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization.
Williamson TH; Baxter GM
Ophthalmology; 1994 Aug; 101(8):1362-72. PubMed ID: 7520147
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
18. Natural history of visual outcome in central retinal vein occlusion.
Hayreh SS; Podhajsky PA; Zimmerman MB
Ophthalmology; 2011 Jan; 118(1):119-133.e1-2. PubMed ID: 20723991
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.
Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
Ophthalmology; 2012 Jun; 119(6):1184-9. PubMed ID: 22424833
[TBL] [Abstract][Full Text] [Related]
20. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
Ophthalmology; 2012 Dec; 119(12):2587-91. PubMed ID: 22902212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
